TNFAIP6 and gastric cancer: Previous research demonstrated that increased TNFAIP6 expression is linked to the level of infiltration, lymph node metastases, and poor outcome in GC patients, implying that TNFAIP6 may be a workable therapeutic target for GC (Zhang et al., 2021).